No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
92 |
4. Check minimum number of eventsNone |
92 |
5. Include endpointsNone |
92 |
6. Filter based on genotype QC (FinnGen only) |
92 |
Control definitions (FinnGen only)
- Control exclude
- Q17_CONGEN_MALFO_DEFORMAT_MUSCULOS_SYSTEM
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Q6[5-9]|Q7
- Name in latin
- Defectus reductionales membri superioris
Similar endpoints
↥List of similar endpoints to
Reduction defects of upper limb
based on the number of shared cases.
Similar with more cases:
- Congenital malformations and deformations of the musculoskeletal system
- Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly
- Congenital malformations, deformations and chromosomal abnormalities
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1190 | 518 | 671 |
| Only index persons | 956 | 441 | 515 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.01 | 0.02 |
| Only index persons | 0.02 | 0.02 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 5.82 | 7.97 | 4.12 |
| Only index persons | 9.08 | 11.27 | 7.20 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 92 | 50 | 42 |
| Unadjusted period prevalence (%) | 0.02 | 0.02 | 0.02 |
| Median age at first event (years) | 22.43 | 19.08 | 26.42 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 85
- Matched controls
- 851
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q71.9
ICD-10 Finland
Reduction defect of upper limb, unspecified
+∞
20.7
19
*
Q71.88
ICD-10 Finland
Other reduction defects of upper limb(s)
+∞
18.4
17
*
Q71.81
ICD-10 Finland
Congenital reduction malformation of thumb
+∞
11.7
11
*
Q71.3
ICD-10 Finland
Congenital absence of hand and finger(s)
+∞
11.7
11
*
Q71.4
ICD-10 Finland
Longitudinal reduction defect of radius
+∞
9.5
9
*
Q71.2
ICD-10 Finland
Congenital absence of both forearm and hand
+∞
8.5
8
*
Q71.80
ICD-10 Finland
Congenital reduction malformation of finger (s)
+∞
8.5
8
*
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
8.5
8.3
18
26
Z2221
NOMESCO Finland
Medical doctor
3.9
7.6
39
153
XF400
NOMESCO Finland
ECG with 12 standard connections
4.5
7.4
29
88
NC2AA
NOMESCO Finland
Forearm X-ray examination
33.1
7.3
9
*
Z3229
NOMESCO Finland
Other healthcare associate professional
5.3
6.9
21
49
ZXD10
NOMESCO Finland
Scheduled procedure
3.4
6.7
46
219
Q71.0
ICD-10 Finland
Congenital complete absence of upper limb(s)
+∞
6.3
6
*
NDT20
NOMESCO Finland
Correction of complicated handanomaly
+∞
6.3
6
*
R4110
NOMESCO Finland
Physiotherapy
3.4
6.3
38
162
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
30
154
2.41
3.53
2.3
2.7
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
47
314
2.02
2.75
7.4
10.2
mmol/l
1.2
1.2
0.32
42
278
(3000764) Benzodiazepines [Presence] in Urine
0
69
0.00
2.74
0.0
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
0
70
0.00
2.73
0.0
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
0
70
0.00
2.73
0.0
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
0
70
0.00
2.73
0.0
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
0
66
0.00
2.53
0.0
1.4
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
14
61
2.53
2.28
8.9
12.3
mmol/l
1.2
1.4
0.58
14
56
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
21
111
2.16
2.24
2.7
2.9
ng/l
825.4
413.8
0.37
14
72
(1001926) Buprenorphine [Presence] in Urine by Screen method
0
58
0.00
2.13
0.0
1.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
31
196
1.88
2.01
1.7
1.9
pmol/l
79.5
92.6
1.42
18
108
(3013139) Helicobacter pylori Ag [Presence] in Stool
9
33
2.91
1.99
1.8
1.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
18
94
2.14
1.97
8.0
11.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
31
198
1.85
1.94
3.3
2.6
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
32
210
1.80
1.83
6.6
4.9
inr
1.2
1.1
—
5
64
(3052851) Hemolysis interference index of Serum or Plasma
7
24
3.07
1.76
3.7
3.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
0
48
0.00
1.76
0.0
1.8
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
19
107
1.98
1.71
2.1
7.6
mmol/l
0.9
0.8
1.33
19
101
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
24
147
1.86
1.69
2.3
3.3
mg/l
2.0
2.0
0.02
16
120
(3014007) Fractional oxyhemoglobin in Arterial blood
8
32
2.64
1.64
11.9
10.6
%
94.6
95.6
—
8
32
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
5
14
3.71
1.63
1.6
1.4
mg/l
9.8
10.1
—
5
14
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
7
26
2.83
1.61
1.3
1.4
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
8
33
2.56
1.58
3.9
9.2
%
223.0
179.5
—
8
33
(3042936) Bacteria identified in Isolate by Culture
16
88
1.99
1.53
1.9
2.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
9
175
0.46
1.49
1.8
2.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
8
160
0.45
1.42
1.8
2.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
17
99
1.88
1.39
1.5
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
9
170
0.48
1.36
1.3
1.7
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
16
255
0.55
1.35
2.0
1.9
—
—
—
0
0
(3012544) pH of Venous blood
17
100
1.86
1.35
3.5
11.7
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
10
48
2.22
1.33
1.2
1.8
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
8
34
2.48
1.33
1.4
1.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
13
70
2.00
1.32
1.3
1.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
63
527
1.62
1.31
3.6
4.7
mm/h
9.4
9.7
0.07
57
491
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
8
36
2.34
1.28
2.6
11.7
%
1.3
1.2
—
8
36
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
38
284
1.58
1.27
4.5
2.9
nmol/l
64.6
71.5
0.84
32
259
(40768443) Skin Pathology biopsy report
6
26
2.40
1.20
1.0
1.2
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
33
0.00
1.19
0.0
1.6
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
33
0.00
1.19
0.0
1.6
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
33
0.00
1.19
0.0
1.6
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
33
0.00
1.19
0.0
1.6
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
20
2.58
1.16
1.0
1.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
5
20
2.58
1.16
1.2
1.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
14
223
0.56
1.16
1.6
2.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
83
761
1.93
1.11
12.8
12.6
mg/l
28.5
24.3
0.50
65
539
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
9
45
2.11
1.08
2.1
3.9
pmol/l
4.4
5.1
—
9
40
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
5
22
2.34
1.04
1.2
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
29
0.00
0.99
0.0
1.6
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
28
0.00
0.99
0.0
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
28
0.00
0.99
0.0
1.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
0
32
0.00
0.97
0.0
1.6
—
—
—
0
0
(3026782) Osmolality of Urine
21
145
1.58
0.96
2.4
2.5
mosm/kgh2o
598.2
605.5
0.04
16
114
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
16
103
1.67
0.95
10.3
11.3
mmol/l
25.4
24.8
0.40
16
103
(3021879) Hepatitis B virus core Ab [Presence] in Serum
10
58
1.81
0.83
1.4
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
0
24
0.00
0.80
0.0
2.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
24
0.00
0.80
0.0
1.1
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
22
160
1.49
0.80
1.8
2.4
e6/l
8.4
4.5
0.54
17
134
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
15
100
1.60
0.79
5.4
7.1
kpa
5.3
5.0
1.33
15
95
(3022145) Colonoscopy Study observation
9
56
1.67
0.75
1.2
1.5
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
25
2.06
0.74
1.2
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
5
25
2.06
0.74
1.0
1.2
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
48
408
1.37
0.74
5.6
5.4
mmol/l
6.3
6.2
0.27
41
370
(3014765) Yersinia sp identified in Stool by Organism specific culture
5
26
1.97
0.72
1.0
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
5
26
1.97
0.72
1.0
1.2
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
51
440
1.36
0.70
8.6
9.2
e9/l
0.2
0.2
1.09
46
392
(40761511) CBC panel - Blood by Automated count
84
794
1.67
0.70
14.4
9.8
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
59
654
0.73
0.69
3.4
3.7
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
5
27
1.90
0.69
2.8
8.5
%
55.4
57.1
—
5
27
(3020891) Body temperature
5
28
1.83
0.67
3.2
7.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
5
28
1.83
0.67
1.2
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
5
28
1.83
0.67
1.2
1.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
20
149
1.44
0.65
4.2
4.8
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
13
88
1.56
0.65
6.0
6.8
mmol/l
25.2
24.1
1.17
13
88
(3004588) Protein electrophoresis panel - Serum or Plasma
5
29
1.76
0.65
1.2
2.4
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
36
298
1.34
0.63
7.3
8.7
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
12
80
1.57
0.63
1.2
1.9
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
51
446
1.32
0.61
7.9
8.2
e9/l
2.1
2.1
0.04
46
402
(3003740) Influenza virus B Ag [Presence] in Specimen
0
21
0.00
0.61
0.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
0
21
0.00
0.61
0.0
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
80
750
1.51
0.60
19.2
13.8
%
38.6
40.0
0.72
62
639
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
22
0.00
0.60
0.0
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
0
23
0.00
0.59
0.0
2.3
—
—
—
0
0
(3013512) EKG study
17
125
1.44
0.59
2.9
3.6
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
6
36
1.71
0.58
1.7
1.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
9
62
1.50
0.55
10.7
7.6
mmol/l
-0.3
1.8
—
9
45
(3006315) Basophils [#/volume] in Blood
49
431
1.29
0.54
8.2
8.3
e9/l
0.0
0.0
0.28
43
378
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
9
63
1.47
0.54
5.4
6.9
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
36
304
1.30
0.54
4.9
4.0
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
49
432
1.29
0.53
8.2
8.2
e9/l
0.5
0.6
0.42
43
379
(3001019) Free T4 and TSH panel - Serum or Plasma
6
40
1.53
0.52
1.0
1.7
—
—
—
0
0
(3022313) Gas panel - Capillary blood
13
94
1.45
0.49
6.3
6.7
—
—
—
0
0
(40758558) Short blood count panel - Blood
30
251
1.29
0.48
8.4
7.6
—
—
—
0
0
(3044889) 12 lead EKG panel
47
417
1.26
0.46
3.8
2.9
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
10
69
1.50
0.46
1.3
1.9
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
7
50
1.43
0.46
2.7
16.4
mg/l
1.1
1.1
—
7
45
(3021589) Normoblasts [#/volume] in Blood
46
409
1.25
0.44
9.4
10.3
e9/l
0.0
0.0
0.49
38
323
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
5
32
1.59
0.43
1.6
1.3
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
8
59
1.39
0.42
4.4
1.8
nmol/l
7.5
12.0
—
8
49
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
0
15
0.00
0.41
0.0
5.9
—
99.1
—
0
15
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
2.8
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
0
16
0.00
0.41
0.0
3.6
—
3.9
—
0
16
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
0
16
0.00
0.41
0.0
3.7
—
56.5
—
0
16
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
0
17
0.00
0.41
0.0
1.6
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
4.1
—
14.2
—
0
18
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
0
19
0.00
0.39
0.0
2.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
28
238
1.25
0.39
2.7
3.2
e6/l
35.1
14.4
0.56
22
183
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
16
128
1.30
0.35
2.4
3.2
e6/l
1.2
2.5
—
10
78
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
10
74
1.39
0.34
1.3
2.0
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
15
120
1.30
0.32
1.5
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
16
193
0.79
0.30
1.9
2.7
—
—
—
0
0
(3002256) Pathology report gross observation
8
65
1.25
0.28
1.1
1.3
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
53
493
1.18
0.28
15.6
10.9
e9/l
4.2
3.9
0.26
48
427
(3000492) Spirometry study
5
72
0.68
0.27
2.0
1.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
14
114
1.27
0.27
2.8
4.5
%
19.1
23.0
—
5
56
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
29
257
1.19
0.26
3.9
3.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
9
73
1.26
0.26
1.1
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
17
143
1.23
0.25
3.1
3.1
mg/l
97.7
105.8
—
10
92
(21494755) Public health laboratory ask at order entry panel
6
83
0.70
0.25
1.3
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
12
97
1.27
0.24
1.4
1.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
16
188
0.82
0.24
6.2
3.4
estimate
0.0
0.0
—
5
62
(3019060) Gas panel - Arterial blood
5
37
1.37
0.24
1.2
4.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
24
270
0.85
0.23
4.5
3.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
12
98
1.26
0.22
1.3
2.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
16
136
1.21
0.22
2.1
3.2
e6/l
0.9
0.8
—
9
86
(4268621)
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
3.9
—
14.7
—
0
10
(4094501)
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.8
—
1151.9
—
0
10
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
0
13
0.00
0.21
0.0
2.0
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
0
13
0.00
0.21
0.0
2.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
0
13
0.00
0.21
0.0
2.0
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
0
13
0.00
0.21
0.0
2.0
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
30
272
1.15
0.20
3.5
3.8
e6/l
16.7
33.5
0.75
22
191
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
0
14
0.00
0.20
0.0
1.9
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
14
0.00
0.20
0.0
5.1
—
—
—
0
0
(44790047)
0
14
0.00
0.20
0.0
2.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
0
14
0.00
0.20
0.0
1.9
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
2.4
—
—
—
0
0
(44790049)
0
14
0.00
0.20
0.0
2.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(44790048)
0
14
0.00
0.20
0.0
2.1
—
—
—
0
0
(44806118)
0
14
0.00
0.20
0.0
2.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
52
491
1.14
0.19
3.3
3.9
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
27
245
1.14
0.18
1.3
1.5
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
24
216
1.15
0.18
2.5
3.3
e6/l
0.3
0.4
0.29
17
161
(36304419) Bacteria [Presence] in Urine
24
216
1.15
0.18
2.5
3.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
5
66
0.74
0.17
1.2
1.9
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
17
149
1.17
0.17
3.6
3.8
mg/mmol
16.0
12.8
—
10
94
(3019832) Treponema pallidum Ab [Presence] in Serum
11
129
0.83
0.16
1.5
1.8
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
61
587
1.12
0.14
12.7
9.5
ml/min/173m2
96.5
93.5
0.24
46
433
(3036481) Cortisol [Moles/volume] in Serum or Plasma
8
96
0.82
0.14
2.1
2.2
nmol/l
411.4
353.9
—
8
90
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
21
191
1.13
0.13
3.4
2.8
ng/l
292.5
23.7
0.51
12
106
(3011397) Hemoglobin [Presence] in Urine by Test strip
19
174
1.12
0.10
4.8
3.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
5
47
1.07
0.09
7.2
3.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
18
165
1.11
0.09
1.4
1.7
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
5
48
1.04
0.09
2.6
3.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
6
56
1.08
0.09
1.0
1.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
7
64
1.10
0.08
2.1
4.6
—
0.4
—
0
14
(3007164) IgA [Mass/volume] in Serum or Plasma
24
255
0.92
0.08
1.8
1.6
g/l
2.1
1.9
0.15
15
141
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
64
625
1.08
0.08
3.9
3.6
mmol/l
5.9
5.7
0.20
59
571
(3035350) Ketones [Presence] in Urine by Test strip
34
353
0.94
0.06
3.7
3.2
estimate
0.0
0.0
—
5
61
(40768804) Tissue Pathology biopsy report
25
240
1.06
0.04
1.7
1.9
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
25
260
0.95
0.04
1.8
1.5
u/ml
2.3
1.3
—
8
56
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
10
92
1.10
0.03
2.7
2.9
mmol/l
2.5
2.4
—
10
81
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
11
118
0.92
0.03
1.5
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
21
212
0.99
0.00
1.5
2.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
18
177
1.02
0.00
2.1
2.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
18
177
1.02
0.00
4.4
5.8
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
71
706
1.02
0.00
22.4
15.0
%
13.7
13.4
1.16
71
695
(3005570) Glucose [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
0
5
0.00
0.00
0.0
15.8
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
58.4
—
0
5
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.8
—
12.5
—
0
6
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(4211845)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3012565) Volume of 24 hour Urine
0
5
0.00
0.00
0.0
1.6
—
2090.0
—
0
5
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022670) pH of Venous cord blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
35
350
1.00
0.00
4.3
4.6
estimate
0.0
0.0
—
5
65
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(4198724)
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
0
7
0.00
0.00
0.0
3.1
—
92.5
—
0
7
(3006922) Hepatitis E virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
9
0.00
0.00
0.0
1.6
—
13.2
—
0
9
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
6.6
—
197.1
—
0
5
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
8
86
0.92
0.00
1.5
6.3
umol/l
9.1
8.1
—
8
74
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
6
60
1.00
0.00
1.5
2.2
u/l
18.2
27.5
—
6
48
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
7.3
—
0
7
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
3.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024471) HLA-A [Type]
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
8
79
1.01
0.00
1.5
1.3
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
0
7
0.00
0.00
0.0
4.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
3.4
—
25.1
—
0
9
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
0.4
—
0
7
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
8
0.00
-0.00
0.0
1.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
8
0.00
-0.00
0.0
2.1
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
8
0.00
-0.00
0.0
15.0
—
10.4
—
0
8
(40768441) Liver Pathology biopsy report
0
8
0.00
-0.00
0.0
1.8
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
0
8
0.00
-0.00
0.0
51.4
—
7.1
—
0
8
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
0
8
0.00
-0.00
0.0
1.9
—
3.2
—
0
8
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
8
0.00
-0.00
0.0
2.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint Q17_REDUCT_DEFECTS_UPPER_LIMB and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have Q17_REDUCT_DEFECTS_UPPER_LIMB.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: Q17_REDUCT_DEFECTS_UPPER_LIMB – Reduction defects of upper limb
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data